Dequan Liu

7PUBLICATIONS
10CO-AUTHORS
Molecular targetsMedical molecular engineering of nucleic acids and proteinsNanomaterialsGlycoconjugatesSolid tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Sep 27, 2026
MLN4924 suppresses kidney renal clear cell carcinoma progression through coordinated inhibition of Cullin1 neddylation and PSMB10-associated NF-κB inflammatory signaling.

|Sep 07, 2026
N-Myristoylation: A Central Hub Integrating Tumor Signaling, Metabolism, and Immunity for Precision Therapy.

|Mar 20, 2026
Nanomedicines Reshape the Tumor Microenvironment: Multidimensional Strategies from Modulating "Barriers" to Metabolic Intervention.

Xinming Zhao, Dequan Liu, Guandu Li

|Feb 27, 2026
Frontiers in Antibody-Drug Conjugates: Mechanisms, Design Innovations, and Clinical Applications in Targeted Cancer Therapy.

Xinghan Li, Jiaming Liu, Yitong Meng

|Dec 23, 2024
A Novel Approach for Bladder Cancer Treatment: Nanoparticles as a Drug Delivery System.

Xinming Zhao, Xiaochen Qi, Dequan Liu

|Aug 29, 2024
Advancements and Challenges in Peptide-Based Cancer Vaccination: A Multidisciplinary Perspective.

Dequan Liu, Lei Liu, Xinghan Li

Pageof 2

Frequent Collaborators

2 joint publications

Shijin Wang

2 joint publications

Guangzhen Wu

1 joint publications

Xiangyu Che

1 joint publications

Xiaochen Qi